Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-amino-7-methyl-3,7-dihydro-6H-purine-6-thione is a heterocyclic organic compound belonging to the purine family. It is characterized by a six-membered ring structure with a sulfur atom at the 6th position, an amino group at the 2nd position, and a methyl group at the 7th position. 2-amino-7-methyl-3,7-dihydro-6H-purine-6-thione is an intermediate in the synthesis of various biologically active molecules, such as nucleosides and nucleotides, which play crucial roles in cellular metabolism and genetic information storage. Due to its unique structure, it has potential applications in the development of pharmaceuticals and therapeutic agents.

7329-79-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7329-79-5 Structure
  • Basic information

    1. Product Name: 2-amino-7-methyl-3,7-dihydro-6H-purine-6-thione
    2. Synonyms:
    3. CAS NO:7329-79-5
    4. Molecular Formula: C6H7N5S
    5. Molecular Weight: 181.2183
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 7329-79-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 488.1°C at 760 mmHg
    3. Flash Point: 249°C
    4. Appearance: N/A
    5. Density: 1.78g/cm3
    6. Vapor Pressure: 1.12E-09mmHg at 25°C
    7. Refractive Index: 1.9
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 2-amino-7-methyl-3,7-dihydro-6H-purine-6-thione(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-amino-7-methyl-3,7-dihydro-6H-purine-6-thione(7329-79-5)
    12. EPA Substance Registry System: 2-amino-7-methyl-3,7-dihydro-6H-purine-6-thione(7329-79-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 7329-79-5(Hazardous Substances Data)

7329-79-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7329-79-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,2 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7329-79:
(6*7)+(5*3)+(4*2)+(3*9)+(2*7)+(1*9)=115
115 % 10 = 5
So 7329-79-5 is a valid CAS Registry Number.

7329-79-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-7-methyl-3H-purine-6-thione

1.2 Other means of identification

Product number -
Other names 2-amino-6-mercapto-7-methylpurine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7329-79-5 SDS

7329-79-5Relevant articles and documents

Purine nucleoside phosphorylase-catalyzed, phosphate-independent hydrolysis of 2-amino-6-mercapto-7-methylpurine ribonucleoside

Cheng, Jianming,Farutin, Victor,Wu, Zhijun,Jacob-Mosier, Gayatry,Riley, Brad,Hakimi, Ryan,Cordes, Eugene H.

, p. 307 - 325 (1999)

In the presence of 1 mM phosphate, 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) is a well-behaved substrate for calf spleen purine nucleoside phosphorylase (PNP). In the absence of phosphate, calf spleen PNP catalyzes a slow hydrolysis of MESG, which is accompanied by inactivation of the enzyme, analogous to the previously observed PNP-catalyzed hydrolysis of inosine and guanosine with formation, in the former case, of a stable PNP·hypoxanthine complex (P.C. Kline and V.L. Schramm (1992) Biochemistry 31, 5964-5973). Qualitative and semiquantitative features of calf spleen PNP- catalyzed hydrolysis of MESG are accounted for by the following model. First, in the absence of phosphate and at pH 7.4, the enzyme exists as an equilibrium mixture of monomer and trimer with a dissociation constant for the trimer of 3 x 1014 M2. Second, a stoichiometric reaction between three molecules of MESG and the PNP trimer results in the formation of a stable PNP·purinethiol complex. Third, the PNP·purinethiol complex initially formed with the monomeric enzyme partitions between product release and formation of a stable complex with 55 turnovers per inactivation event. Fourth, the stable PNP·purinethiol complexes are rapidly dissociated by phosphate to regenerate active enzyme. This dissociation is accompanied by an increase in absorbance at 356 nm consistent with a pK(a) for the purinethiol base on the enzyme of 8.1, compared to a corresponding value of 8.8 in aqueous solution.

Synthesis of a C-phosphonate mimic of maltose-1-phosphate and inhibition studies on Mycobacterium tuberculosis GlgE

Veleti, Sri Kumar,Lindenberger, Jared J.,Ronning, Donald R.,Sucheck, Steven J.

, p. 1404 - 1411 (2014/03/21)

The emergence of extensively drug-resistant tuberculosis (XDR-TB) necessitates the need to identify new anti-tuberculosis drug targets as well as to better understand essential biosynthetic pathways. GlgE is a Mycobacterium tuberculosis (Mtb) encoded maltosyltransferase involved in α-glucan biosynthesis. Deletion of GlgE in Mtb results in the accumulation of M1P within cells leading to rapid death of the organism. To inhibit GlgE a maltose-C-phosphonate (MCP) 13 was designed to act as an isosteric non-hydrolysable mimic of M1P. MCP 13, the only known inhibitor of Mtb GlgE, was successfully synthesized using a Wittig olefination as a key step in transforming maltose to the desired product. MCP 13 inhibited Mtb GlgE with an IC50 = 230 ± 24 μM determined using a coupled enzyme assay which measures orthophosphate release. The requirement of M1P for the assay necessitated the development of an expedited synthetic route to M1P from an intermediate used in the MCP 13 synthesis. In conclusion, we designed a substrate analogue of M1P that is the first to exhibit Mtb GlgE inhibition.

Synthesis and evaluation of l-rhamnose 1C-phosphonates as nucleotidylyltransferase inhibitors

Loranger, Matthew W.,Forget, Stephanie M.,McCormick, Nicole E.,Syvitski, Raymond T.,Jakeman, David L.

, p. 9822 - 9833 (2013/10/22)

We report the synthesis of a series of phosphonates and ketosephosphonates possessing an l-rhamnose scaffold with varying degrees of fluorination. These compounds were evaluated as potential inhibitors of α-d-glucose 1-phosphate thymidylyltransferase (Cps2L), the first enzyme in Streptococcus pneumoniae l-rhamnose biosynthesis, and a novel antibiotic target. Enzyme-substrate and enzyme-inhibitor binding experiments were performed using water-ligand observed binding via gradient spectroscopy (WaterLOGSY) NMR for known sugar nucleotide substrates and selected phosphonate analogues. IC 50 values were measured and Ki values were calculated for inhibitors. New insights were gained into the binding promiscuity of enzymes within the prokaryotic l-rhamnose biosynthetic pathway (Cps2L, RmlB-D) and into the mechanism of inhibition for the most potent inhibitor in the series, l-rhamnose 1C-phosphonate.

Nucleotidylation of unsaturated carbasugar in validamycin biosynthesis

Yang, Jongtae,Xu, Hui,Zhang, Yirong,Bai, Linquan,Deng, Zixin,Mahmud, Taifo

experimental part, p. 438 - 449 (2011/03/17)

Validamycin A is a member of microbial-derived C7N-aminocyclitol family of natural products that is widely used as crop protectant and the precursor of the antidiabetic drug voglibose. Its biosynthetic gene clusters have been identified in seve

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7329-79-5